The Extracellular Matrix Metalloproteinase Inducer (EMMPRIN, CD147) - A potential novel target in atherothrombosis prevention?

Thrombosis Research

Volumn 131, Issue 6, 2013, Pages 474-480

  Joghetaei, Nader ^a   Stein, Andreas ^a   Byrne, Robert A ^a   Schulz, Christian ^b,c   King, Lamin ^a   May, Andreas E ^d   Schmidt, Roland ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b BHF Centre of Excellence   (United Kingdom)

^c KING'S COLLEGE LONDON   (United Kingdom)

^d UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

Atherogenesis; Atherothrombosis; EMMPRIN

Indexed keywords

CD147 ANTIGEN; LIPOPROTEIN;

ACUTE CORONARY SYNDROME; ATHEROGENESIS; CEREBROVASCULAR ACCIDENT; DISEASE COURSE; INNATE IMMUNITY; LEUKOCYTE MIGRATION; PLEIOTROPY; PRIORITY JOURNAL; REVIEW; THROMBOSIS;

ANIMALS; ANTIGENS, CD147; ARTERIES; ATHEROSCLEROSIS; COLLAGENASES; HUMANS; INFLAMMATION;

EID: 84878880586     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/j.thromres.2013.04.017     Document Type: Review

References (52)

1. C. Biswas Tumor cell stimulation of collagenase production by fibroblasts Biochem Biophys Res Commun 109 1982 1026 1034
2. T. Sameshima, K. Nabeshima, B.P. Toole, K. Yokogami, Y. Okada, and T. Goya Glioma cell extracellular matrix metalloproteinase inducer (EMMPRIN) (CD147) stimulates production of membrane-type matrix metalloproteinases and activated gelatinase A in co-cultures with brain-derived fibroblasts Cancer Lett 157 2000 177 184
3. C. Biswas, Y. Zhang, R. DeCastro, H. Guo, T. Nakamura, and H. Kataoka The human tumor cell-derived collagenase stimulatory factor (renamed EMMPRIN) is a member of the immunoglobulin superfamily Cancer Res 55 1995 434 439
4. C. Biswas, Y. Zhang, R. DeCastro, H. Guo, T. Nakamura, and H. Kataoka The human tumor cellderived collagenase stimulatory factor (renamed EMMPRIN) is a member of the immunoglobulin superfamily Cancer Res 55 1995 434 439
5. T. Miyauchi, Y. Masuzawa, and T. Muramatsu The basigin group of the immunoglobulin superfamily: complete conservation of a segment in and around transmembrane domains of human and mouse basigin and chicken HT7 antigen J Biochem (Tokyo) 110 1991 770 774
6. T. Muramatsu, and T. Miyauchi Basigin (CD147): a multifunctional transmembrane protein involved in reproduction, neural function, inflammation and tumor invasion Histol Histopathol 18 2003 981 987
7. R. Li, L. Huang, H. Guo, and B.P. Toole Basigin (murine EMMPRIN) stimulates matrix metalloproteinase production by fibroblasts J Cell Physiol 186 2001 371 379
8. J. Sun, and M.E. Hemler Regulation of MMP-1 and MMP-2 production through CD147/extracellular matrix metalloproteinase inducer interactions Cancer Res 61 2001 2276 2281
9. F. Berditchevski, S. Chang, J. Bodorova, and M.E. Hemler Generation of monoclonal antibodies to integrin-associated proteins. Evidence that alpha3beta1 complexes with EMMPRIN/basigin/OX47/M6 J Biol Chem 27 1997 29174 29180
10. W. Tang, and M.E. Hemler Caveolin-1 regulates matrix metalloproteinases-1 induction and CD147/EMMPRIN cell surface clustering J Biol Chem 279 2004 11112 11118
11. M. Lim, T. Martinez, D. Jablons, R. Cameron, H. Guo, and B. Toole Tumor-derived EMMPRIN (extracellular matrix metalloproteinase inducer) stimulates collagenase transcription through MAPK p38 FEBS Lett 441 1998 88 92
12. P.M. Taylor, R.J. Woodfield, M.N. Hodgkin, T.R. Pettitt, A. Martin, and D.J. Kerr Breast cancer cell-derived EMMPRIN stimulates fibroblast MMP2 release through a phospholipase A(2) and 5-lipoxygenase catalyzed pathway Oncogene 21 2002 5765 5772
13. H. Kataoka, R. DeCastro, S. Zucker, and C. Biswas Tumor cell-derived collagenase-stimulatory factor increases expression of interstitial collagenase, stromelysin, and 72-kDa gelatinase Cancer Res 53 1993 3154 3158
14. G. Camejo, E. Hurt-Camejo, O. Wiklund, and G. Bondjers Association of apo B lipoproteins with arterial proteoglycans: pathological significance and molecular basis Atherosclerosis 139 1998 205 222
15. J.L. Witztum, and J.A. Berliner Oxidized phospholipids and isoprostanes in atherosclerosis Curr Opin Lipidol 9 1998 441 448
16. A.E. May, R. Schmidt, B.O. Bulbul, M. Holderle, F. Walther, and A. Schomig Plasminogen and matrix metalloproteinase activation by enzymatically modified low density lipoproteins in monocytes and smooth muscle cells Thromb Haemost 93 2005 710 715
17. P. Seizer, T. Schönberger, M. Schött, M.R. Lang, H.F. Langer, and B. Bigalke EMMPRIN and its ligand cyclophilin A regulate MT1-MMP, MMP-9 and M-CSF during foam cell formation Atherosclerosis 209 2010 51 57
18. J. Zhou, P. Zhu, J.L. Jiang, Q. Zhang, Z.B. Wu, and X.Y. Yao Involvement of CD147 in overexpression of MMP-2 and MMP-9 and enhancement of invasive potential of PMA-differentiated THP-1 BMC Cell Biol 6 2005 25
19. J.M. Damsker, I. Okwumabua, T. Pushkarsky, K. Arora, M.I. Bukrinsky, and S.L. Constant Targeting the chemotactic function of CD147 reduces collagen-induced arthritis Immunology 126 2009 55 62
20. W.M. Gwinn, J.M. Damsker, R. Falahati, I. Okwumabua, A. Kelly-Welch, and A.D. Keegan Novel approach to inhibit asthma-mediated lung inflammation using anti-CD147 intervention J Immunol 177 2006 4870 4879
21. P. Seizer, T. Geisler, B. Bigalke, M. Schneider, K. Klingel, and R. Kandolf EMMPRIN and its ligand Cyclophilin A as novel diagnostic markers in inflammatory cardiomyopathy Int J Cardiol 163 2013 299 304
22. W. Kasinrerk, N. Tokrasinwit, and P. Phunpae CD147 monoclonal antibodies induce homotypic cell aggregation of monocytic cell line U937 via LFA-1/ICAM-1 pathway Immunology 96 1999 184 192
23. J. Zhang, H. Ge, C. Wang, T.B. Guo, Q. He, and Q. Shao Inhibitory effect of PPAR on the expression of EMMPRIN in macrophages and foam cells Int J Cardiol 117 2007 373 380
24. H.H. Yue, N. Leng, Z.B. Wu, H.M. Li, X.Y. Li, and P. Zhu Expression of CD147 on phorbol-12 myristate-13-acetate (PMA)-treated U937 cells differentiating into foam cells Arch Biochem Biophys 485 2009 30 34
25. T.B. Rajavashisth, J.K. Liao, Z.S. Galis, S. Tripathi, U. Laufs, and J. Tripathi Inflammatory cytokines and oxidized low density lipoproteins increase endothelial cell expression of membrane type 1-matrix metalloproteinase J Biol Chem 274 1999 11924 11929
26. S. Rajagopalan, X.P. Meng, S. Ramasamy, D.G. Harrison, and Z.S. Galis Reactive oxygen species produced by macrophage-derived foam cells regulate the activity of vascular matrix metalloproteinases in vitro. Implications for atherosclerotic plaque stability J Clin Invest 98 1996 2572 2579
27. Y. Castier, R.P. Brandes, G. Leseche, A. Tedgui, and S. Lehoux p47phox-dependent NADPH oxidase regulates flow-induced vascular remodeling Circ Res 97 2005 533 540
28. K. Satoh, P. Nigro, T. Matoba, M.R. O'Dell, Z. Cui, and X. Shi Cyclophilin A enhances vascular oxidative stress and the development of angiotensin II-induced aortic aneurysms Nat Med 15 2009 649 656
29. C. Doerries, K. Grote, D. Hilfiker-Kleiner, M. Luchtefeld, A. Schaefer, and S.M. Holland Critical role of the NAD(P)H oxidase subunit p47phox for left ventricular remodeling/dysfunction and survival after myocardial infarction Circ Res 100 2007 894 903
30. P. Seizer, C. Ochmann, T. Schönberger, S. Zach, M. Rose, and O. Borst Disrupting the EMMPRIN (CD147)-cyclophilin A interaction reduces infarct size and preserves systolic function after myocardial ischemia and reperfusion Arterioscler Thromb Vasc Biol 31 2011 1377 1386
31. A. Angelillo-Scherrer Leukocyte-derived microparticles in vascular homeostasis Circ Res 110 2012 356 369
32. M. Baron, C.M. Boulanger, B. Staels, and A. Tailleux Cell-derived microparticles in atherosclerosis: biomarkers and targets for pharmacological modulation? J Cell Mol Med 16 2012 1365 1376
33. J. Baran, M. Baj-Krzyworzeka, K. Weglarczyk, R. Szatanek, M. Zembala, and J. Barbasz Circulating tumour-derived microvesicles in plasma of gastric cancer patients Cancer Immunol Immunother 59 2010 841 850
34. G.K. Hansson, P. Libby, U. Schönbeck, and Z.Q. Yan Innate and adaptive immunity in the pathogenesis of atherosclerosis Circ Res 91 2002 281 291
35. C.J. Binder, M.K. Chang, P.X. Shaw, Y.I. Miller, K. Hartvigsen, and A. Dewan Innate and acquired immunity in atherogenesis Nat Med 8 2002 1218 1226
36. R. Schmidt, V. Redecke, Y. Breitfeld, N. Wantia, T. Miethke, and S. Massberg EMMPRIN (CD 147) is a Central Activator of Extracellular Matrix Degradation by Chlamydia pneumoniae-infected Monocytes. Implications for plaque rupture Thromb Haemost 95 2006 151 159
37. L.J. Pinderski, M.P. Fischbein, G. Subbanagounder, M.C. Fishbein, N. Kubo, and H. Cheroutre Overexpression of interleukin-10 by activated T lymphocytes inhibits atherosclerosis in LDL receptor-deficient Mice by altering lymphocyte and macrophage phenotypes Circ Res 90 2002 1064 1071
38. Z. Huang, C. Wang, L. Wei, J. Wang, Y. Fan, and L. Wang Resveratrol inhibits EMMPRIN expression via P38 and ERK1/2 pathways in PMAinduced THP-1 cells Biochem Biophys Res Commun 374 2008 517 521
39. I. Manabe, and R. Nagai Regulation of smooth muscle phenotype Curr Atheroscler Rep 5 2003 214 222
40. C. Haug, C. Lenz, F. Díaz, and M.G. Bachem Oxidized low-density lipoproteins stimulate extracellular matrix metalloproteinase Inducer (EMMPRIN) release by coronary smooth muscle cells Arterioscler Thromb Vasc Biol 24 2004 1823 1829
41. J.P. Sluijter, W.P. Pulskens, A.H. Schoneveld, E. Velema, C.F. Strijder, and F. Moll Matrix metalloproteinase 2 is associated with stable and matrix metalloproteinases 8 and 9 with vulnerable carotid atherosclerotic lesions: a study in human endarterectomy specimen pointing to a role for different extracellular matrix metalloproteinase inducer glycosylation forms Stroke 37 2006 235 239
42. T. Kanekura, T. Miyauchi, M. Tashiro, and T. Muramatsu Basigin, a new member of the immunoglobulin superfamily: genes in different mammalian species, glycosylation changes in the molecule from adult organs and possible variation in the N-terminal sequences Cell Struct Funct 16 1991 23 30
43. W. Chang, S. Lim, H. Song, B.W. Song, H.J. Kim, and M.J. Cha Cordycepin inhibits vascular smooth muscle cell proliferation Eur J Pharmacol 597 2008 64 69
44. B. Venkatesan, A.J. Valente, V. Seenu Reddy, D.A. Siwik, and B. Chandrasekar Resveratrol Blocks Interleukin-18-EMMPRIN Crossregulation and Smooth Muscle Cell Migration Am J Physiol Heart Circ Physiol 297 2009 H874 H886
45. Y. Chen, H. Zhang, X. Gou, Y. Horikawa, J. Xing, and Z. Chen Upregulation of HAb18G/CD147 in activated human umbilical vein endothelial cells enhances the angiogenesis Cancer Lett 278 2009 113 121
46. H. Voigt, C.S. Vetter-Kauczok, D. Schrama, U.B. Hofmann, J.C. Becker, and R. Houben CD147 impacts angiogenesis and metastasis formation Cancer Invest 27 2009 329 333
47. M.I. Furman, M.R. Barnard, L.A. Krueger, M.L. Fox, E.A. Shilale, and D.M. Lessard Circulating monocyte-platelet aggregates are an early marker of acute myocardial infarction J Am Coll Cardiol 38 2001 1002 1006
48. R. Schmidt, A. Bültmann, S. Fischel, A. Gillitzer, P. Cullen, and A. Walch Extracellular matrix metalloproteinase inducer (CD147) is a novel receptor on platelets, activates platelets, and augments nuclear factor kappaB-dependent inflammation in monocytes Circ Res 102 2008 302 309
49. C. Schulz, M.L. von Brühl, V. Barocke, P. Cullen, K. Mayer, and R. Okrojek EMMPRIN (CD147/basigin) mediates platelet-monocyte interactions in vivo and augments monocyte recruitment to the vascular wall J Thromb Haemost 9 2011 1007 1019
50. P. Seizer, O. Borst, H.F. Langer, A. Bültmann, G. Münch, and Y. Herouy EMMPRIN (CD147) is a novel receptor for platelet GPVI and mediates platelet rolling via GPVI-EMMPRIN interaction Thromb Haemost 101 2009 682 686
51. R. Virmani, A.P. Burke, A. Farb, and F.D. Kolodgie Pathology of the vulnerable plaque J Am Coll Cardiol 47 8 Suppl. 2006 C13 C18
52. R. Schmidt, A. Bültmann, M. Ungerer, N. Joghetaei, Ö. Bülbül, and S. Thieme EMMPRIN regulates MMP activity in cardiovascular cells. Implications in Acute Myocardial Infarction Circulation 113 2006 834 841